We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
-14.12%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$2.6B
AUM Growth
+$351M
Cap. Flow
+$870M
Cap. Flow %
33.44%
Top 10 Hldgs %
12.89%
Holding
1,330
New
552
Increased
277
Reduced
191
Closed
296

Sector Composition

Rank Sector Weight
1 Healthcare 18.41%
2 Industrials 14.41%
3 Consumer Discretionary 13.15%
4 Technology 10.64%
5 Financials 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEB icon
176
Pebblebrook Hotel Trust
PEB
$2.1B
$4.19M 0.16%
+148,016
New +$4.91M
KIDS icon
177
OrthoPediatrics
KIDS
$517M
$4.15M 0.16%
118,900
+43,900
+59% +$1.39M
EQC
178
DELISTED
Equity Commonwealth
EQC
$4.1M 0.16%
136,500
+77,300
+131% +$2.35M
VCEL icon
179
Vericel Corp
VCEL
$2.43B
$4.09M 0.16%
235,000
-136,600
-37% -$2.04M
TVTY
180
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$4.07M 0.16%
164,029
+143,729
+708% +$4.78M
SNPS icon
181
Synopsys
SNPS
$71.3B
$4.07M 0.16%
48,275
-10,801
-18% -$960K
BLFS icon
182
BioLife Solutions
BLFS
$1.55B
$4.05M 0.16%
336,700
-31,800
-9% -$380K
STL
183
DELISTED
Sterling Bancorp
STL
$4.04M 0.16%
+244,900
New +$4.56M
ROK icon
184
Rockwell Automation
ROK
$52.4B
$4.04M 0.16%
26,814
+17,814
+198% +$2.97M
DAN icon
185
Dana Inc
DAN
$2.91B
$4.03M 0.16%
295,769
+102,369
+53% +$1.55M
BAX icon
186
Baxter International
BAX
$13.8B
$4.03M 0.15%
61,200
-58,800
-49% -$3.95M
PM icon
187
Philip Morris
PM
$299B
$4.02M 0.15%
+60,228
New +$5.03M
SPCE icon
188
Virgin Galactic
SPCE
$329M
$4M 0.15%
20,000
CAH icon
189
Cardinal Health
CAH
$53.2B
$4M 0.15%
+89,639
New +$4.67M
CBOE icon
190
Cboe Global Markets
CBOE
$31B
$3.92M 0.15%
40,032
+16,432
+70% +$1.71M
ZBRA icon
191
Zebra Technologies
ZBRA
$13.7B
$3.89M 0.15%
24,433
+19,778
+425% +$3.29M
MRTX
192
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$3.86M 0.15%
90,900
+36,400
+67% +$1.45M
MU icon
193
Micron Technology
MU
$988B
$3.84M 0.15%
+121,068
New +$4.59M
ICE icon
194
Intercontinental Exchange
ICE
$87.7B
$3.81M 0.15%
+50,600
New +$3.88M
ALDR
195
DELISTED
Alder Biopharmaceuticals
ALDR
$3.81M 0.15%
371,700
+18,000
+5% +$230K
ANAB icon
196
AnaptysBio
ANAB
$1.63B
$3.81M 0.15%
59,700
+20,000
+50% +$1.49M
GPK icon
197
Graphic Packaging
GPK
$3.24B
$3.78M 0.15%
+355,111
New +$4.16M
GE icon
198
GE Aerospace
GE
$368B
$3.72M 0.14%
+186,043
New +$8.4M
CRL icon
199
Charles River Laboratories
CRL
$11.3B
$3.71M 0.14%
32,743
+11,491
+54% +$1.44M
GT icon
200
Goodyear
GT
$2.04B
$3.7M 0.14%
181,300
-117,000
-39% -$2.53M

Similar funds

Schonfeld Strategic Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Schonfeld Strategic Advisors held 1,330 positions worth $2.6B, up 16% from $2.25B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Schonfeld Strategic Advisors deployed $870M of net new capital in Q4 2018, opening 552 new positions and adding to 277 existing holdings. Its largest new stake was Shire pic: 183,006 shares worth $31.8M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Fortive, an estimated $26.5M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2018 buy was Shire pic: 183,006 shares worth $31.8M.
  • Schonfeld Strategic Advisors added most to Plains GP Holdings in Q4 2018, an estimated $26.5M increase.
  • Schonfeld Strategic Advisors's biggest Q4 2018 reduction was Fortive, cutting an estimated $26.5M.
  • Schonfeld Strategic Advisors fully exited Churchill Capital Corp in Q4 2018, selling an estimated $20.3M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 13% of its $2.6B portfolio in Q4 2018.
  • Schonfeld Strategic Advisors opened 552 new positions and closed 296 in Q4 2018.
  • Schonfeld Strategic Advisors's portfolio value rose 16% quarter-over-quarter to $2.6B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.